CN104886594A - Preparation method of siraitia grosvenorii compound capsules - Google Patents
Preparation method of siraitia grosvenorii compound capsules Download PDFInfo
- Publication number
- CN104886594A CN104886594A CN201510298167.5A CN201510298167A CN104886594A CN 104886594 A CN104886594 A CN 104886594A CN 201510298167 A CN201510298167 A CN 201510298167A CN 104886594 A CN104886594 A CN 104886594A
- Authority
- CN
- China
- Prior art keywords
- momordica grosvenori
- extract
- dry
- compound
- raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 title claims abstract description 83
- 150000001875 compounds Chemical class 0.000 title claims abstract description 49
- 239000002775 capsule Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 241001409321 Siraitia grosvenorii Species 0.000 title 1
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 84
- 239000000284 extract Substances 0.000 claims abstract description 77
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 23
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 23
- 239000000843 powder Substances 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 241001116389 Aloe Species 0.000 claims abstract description 15
- 244000130592 Hibiscus syriacus Species 0.000 claims abstract description 15
- 235000018081 Hibiscus syriacus Nutrition 0.000 claims abstract description 15
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 14
- 235000010676 Ocimum basilicum Nutrition 0.000 claims abstract description 13
- 240000007926 Ocimum gratissimum Species 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229920002261 Corn starch Polymers 0.000 claims abstract description 10
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 10
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 10
- 239000011248 coating agent Substances 0.000 claims abstract description 10
- 238000000576 coating method Methods 0.000 claims abstract description 10
- 239000008120 corn starch Substances 0.000 claims abstract description 10
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 10
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000012141 concentrate Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 16
- 238000004659 sterilization and disinfection Methods 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 10
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 10
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 10
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229940099112 cornstarch Drugs 0.000 claims description 9
- 229930182478 glucoside Natural products 0.000 claims description 9
- 150000008131 glucosides Chemical class 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001728 nano-filtration Methods 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 108090000526 Papain Proteins 0.000 claims description 4
- 238000004440 column chromatography Methods 0.000 claims description 4
- 229940055729 papain Drugs 0.000 claims description 4
- 235000019834 papain Nutrition 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000000409 membrane extraction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000002245 particle Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000007887 hard shell capsule Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- -1 aloe polysaccharide Chemical class 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001471 micro-filtration Methods 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000011122 softwood Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005498 polishing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- HGUVPEBGCAVWID-KETMJRJWSA-N 7-O-(beta-D-glucosyl)isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1O)[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-KETMJRJWSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- HGUVPEBGCAVWID-UHFFFAOYSA-N saponarin Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)C2C(C(O)C(O)C(CO)O2)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 HGUVPEBGCAVWID-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a preparation method of siraitia grosvenorii compound capsules. The preparation method comprises the following steps: crushing raw and auxiliary materials; screening the crushed raw and auxiliary materials; mixing the screened raw and auxiliary materials; pelleting the mixed raw and auxiliary materials; coating the pelleted raw and auxiliary materials; drying the coated raw and auxiliary materials; stuffing the capsules. Each of the siraitia grosvenorii compound capsule comprises the following raw and auxiliary materials in parts by weight: 23-27% of siraitia grosvenorii compound extracts, 5-10% of persimmon powder, 30-35% of corn starch, 25-30% of maltodextrin and 5-10% of microcrystalline cellulose. The siraitia grosvenorii compound extracts use a siraitia grosvenorii extracting solution as a solvent and dried tea leaves of dried aloe leaves, dried shrub althea flowers and dried sweet basil herb as the raw materials so as to perform the extraction, the mass ratio of the dried aloe leaves to the dried shrub althea flowers and the dried sweet basil herb is 2:(0.5-2.0):(1-1.5):(0.1-1), and the material-solvent ratio is 1:(5-10); The siraitia grosvenorii compound capsules prepared by the preparation method disclosed by the invention have the oxidation resistant effect, the bacteriostasis effect and the immunity enhancing effect.
Description
Technical field
The present invention relates to field of plant extraction, especially the preparation method of a Plant Extracts compound capsule.
Background technology
Momordica grosvenori is a kind of " medicine-food two-purpose " rare traditional Chinese medicine, has taste sweet cool in nature, returns lung, large intestine channel, moisten the lung and relieve the cough, the effect promoted the production of body fluid to quench thirst.Current Momordica grosvenori deep processing mainly extracts Momordica grosvenori glucoside, as sweetener.In the process extracting Momordica grosvenori glucoside, also containing abundant nutriment in the Momordica grosvenori extract abandoned, such as momordica grosvenori polysaccharide, fructose, flavones, vitamin C.Think to reclaim processing further, owing to there being the polymer substances such as pectin, dietary fiber, protein, be difficult to carry out with spraying dry so concentrated, cause the Momordica grosvenori extract extracting Momordica grosvenori glucoside material later to abandon, waste Momordica grosvenori resource, brings pressure to environmental protection.Chinese invention patent application publication number is CN101007042A, discloses a kind of decolouring, debitterize, containing the method for preparing extractive of Momordica grosvenori glucoside; This method is after extraction Momordica grosvenori glucoside, and Momordica grosvenori extract can also be recycled.
Tea Polyphenols is the antioxidative food additive extracted from tealeaves, primarily of compositions such as catechin, flavonols, anthocyanidin, phenolic acid, based on catechin.Tea Polyphenols can remove harmful free radicals, blocks lipid peroxidation process, improves the activity of human enzymes, thus plays effect of anti-oxidant, anti-sudden change, anticancer, to the prevention of the kinds cancer such as cancer of the stomach, intestinal cancer and supplemental treatment all helpful.
Aloe is Liliaceae evergreen herbage, containing functional components such as anthraquinone analog compound, aloe polysaccharide, amino acid, organic acid, vitamin, mineral matters, can be used for food, medicine, cosmetics, there is relaxing bowel, improve immunity, moisturizing, beauty treatment, the health-care efficacy such as sterilization.Chinese patent application CN101670037, a kind of compound aloe capsule and preparation method thereof, disclose one with aloe, indigo naturalis, cinnabar and amber for raw material, respectively after Preparation process, Hydrolysis kinetics process, through a kind of hard shell capsules Chinese medicine preparation of the method such as mixing, granulation, filling manufactures, have that clearing liver is purged heat, relaxed bowel, the function of antitoxic heart-soothing and sedative; Described aloe refers to the medicinal aloe in pharmacopeia, and barbaloin content is greater than 18%.
The rose of Sharon, machaka.The flower of the rose of Sharon, really, root, leaf and Pi Junke be used as medicine.There is the effect preventing and treating viral disease and reduce cholesterol.The high nutritive value of shrub althea flower, containing protein, fat, crude fibre, and reduced sugar, vitamin C, amino acid, iron, calcium, zinc etc., and containing flavonoids active material, there is the health-care effect such as restoring consciouness, anti-dandruff and itching-relieving that quenches the thirst.Shrub althea flower is for oral administration controls gastric disorder causing nausea, dysentery, prolapse of the anus, haematemesis, lower blood, mumps, leukorrhea etc., and external application can treat sore furuncle.Shrub althea flower is containing saponarin, isovitexin, saponin etc., and it has certain inhibitory action to staphylococcus aureus and typhoid bacillus, can treat intestines diarrhea due to wind-evil blood.
Sweet basil is " medicine-food two-purpose " Labiatae fragrant plant, have powerful, stimulate, fragrant smell.Sweet basil is containing volatile oil 0.02 ~ 0.04%, and pure Basil Essential has very strong sterilizing rate, main as blending raw material.Sweet basil all herbal medicine, there is treatment headache, nasosinusitis, bronchitis, cold, indigestion, enteritis, diarrhea, staitinodermia, traumatic injuries etc., decoct washing eczema and dermatitis pimples, acne, have to dryness lack of water and aging skin that is coarse, wrinkle the effect of moistening, also can be used for often overtime work and long-term livid ring around eye, the pouch occurred in the face of computer.
Astringent persimmon fruit has another name called Zhu fruit, is the fruit that a kind of nutritive value is very high, enjoys the good reputation of " fruit Zisco product ".Containing about 2.0% puckery persimmon tannin in astringent persimmon fruit, also containing amino acid, trace element, multivitamin, organic acid etc. that carbohydrate, protein, human body are necessary, have suppress human lymphocyte leukaemia, hypotensive, remove the multiple efficacies such as interior free yl, absorption yttrium.Application for a patent for invention CN101328194 discloses a kind of persimmon powder and production technology thereof; It is after being squeezed the juice by persimmon, and juice carries out enzymolysis, filters, the enzyme that goes out, concentrated, vacuum freeze drying and obtained tannin content is the powder of 1% ~ 99%.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of Momordica grosvenori compound capsule preparation method; A kind of Momordica grosvenori compound extract can be obtained by the method, and then obtain a kind of there is Momordica grosvenori compound capsule that is anti-oxidant, antibacterial, develop immunitypty effect.
In order to solve this technical problem, the technical scheme that the present invention takes is:
Part I produces Momordica grosvenori compound extract, and its step is as follows:
1, carry at the beginning of Momordica grosvenori
Take dried fructus momordicae as raw material, adopt pure water to extract, concentrated, column chromatography, wash-out, extracts Momordica grosvenori glucoside material, then reclaims the Momordica grosvenori efflux by column chromatography.
2, with Momordica grosvenori efflux for solvent extracts
By stem tea, dry aloe leaf, dry shrub althea flower, dry sweet basil in mass ratio example weigh up, as raw material; Stem tea: dry aloe leaf: dry shrub althea flower: the ratio of dry sweet basil is 2:(0.5-2.0): (1-1.5): (0.1-1.0), with Momordica grosvenori efflux for solvent extracts, quality solid-liquid ratio is 1:(5-10), be then heated to 70-100 DEG C, time is 4-8 hour, extracts.
3, filter, cool
After extraction terminates, through vibratory sieve, extract is separated with the dregs of a decoction; Then temperature is cooled to by extract to be about 50 DEG C.
4, enzymolysis, decolouring, filtration, sterilization
Example adds the pectase of 0.01-0.1% in mass ratio, the papain of 0.05-0.2%, and the cellulase of 0.05-0.2%, stirs, and control temperature is 40-55 DEG C, and the time is 20-30 minute; Add the active carbon of 0.1%-2.5% again, insulation 30-50 minute, then filters.Enzyme preparation also can first use water-soluble solution, then adds.
Filtration can be plate-frame filtering, or diatomite filtration, obtains cleaner liquid; 0.05-0.5% diatomite drainage can be added, so that filtrate reaches clarification during filtration; Diatomite has dividing of thickness, and when thickness diatomite adds, preferred proportion is 1:1, filters clarification optimum efficiency to reach;
Crossing cleaner liquid adopts instantaneous superhigh temperature to kill bacterium (UHT) sterilization, and sterilization temperature controls at 121-125 DEG C; Or pasteurize, obtains extracting stoste.
5, UF membrane
Extraction stoste is first used micro-filtrate membrane filtration, then concentrates with NF membrane normal temperature.
Preferred film aperture is the microfiltration membranes of 0.45 μm, obtains the filtrate by microfiltration membranes.
Then nanofiltration, by the filtrate by microfiltration membranes at normal temperatures by NF membrane, concentrates at normal temperatures, obtains nanofiltration concentrate; Concentrate can reduced pressure concentration further, obtains high power concentrate.
6, dry
Can be spraying dry, freeze drying or other drying means.By the nanofiltration concentrate that obtains or high power concentrate drying, or pulverize further, obtain Momordica grosvenori compound extract.
The preparation of Part II Momordica grosvenori compound capsule, its step is as follows:
Adopt Momordica grosvenori compound extract and persimmon powder to be raw material, add cornstarch, maltodextrin, the auxiliary materials such as microcrystalline cellulose; Through pulverizing, sieving, mix, granulate, dressing, filling, aluminum-plastic packaged, obtained finished product.
The proportioning of Momordica grosvenori compound capsule is, by butt quality %,
Momordica grosvenori compound extract 23-27;
Persimmon powder 5-10;
Cornstarch 30-35;
Maltodextrin 25-30;
Microcrystalline cellulose 5-10;
Dressing adopts 2.0% hydroxypropyl methylcellulose (HPMC), and coating solution adopts the ethanol of 60% to make solvent, and being made into concentration is 6.0%-8.0% coating solution.
The quality of capsule is every 0.3g.Positive usual amounts is every day 2-3 time, each 1-2 grain.
First each supplementary material is pulverized, cross 200 orders and sieve to 300 objects, then adopt the mixing of V mixer; The ethanol softwood of 95% is selected in granulation, and vibrating sieving machine is granulated, dressing, and then at 35-40 DEG C drying under reduced pressure immediately, to remove ethanol and moisture further, after dry, material moisture controls below 3.0%.Then the hard shell capsules of 0.3g is filled to by 1# capsule shells.
The present invention, under the prerequisite of basic ratio keeping Momordica grosvenori compound extract and persimmon powder, can also make other peroral dosage forms, such as tablet, granule.
The present invention has following advantages and characteristic:
1, comprehensive utilization of resources.The later Momordica grosvenori extract recycling of Momordica grosvenori glucoside material will be extracted, as a kind of solvent, be used for extracting tealeaves, aloe, shrub althea flower, sweet basil, obtain a kind of Momordica grosvenori compound extract, the composite prescription with persimmon powder further again, be processed into compound capsule, Momordica grosvenori resource obtains comprehensive utilization, product effect is unique, reduces cost.
2, combination technique is novel.After reclaiming Momordica grosvenori efflux, as Extraction solvent; 4 kinds of dry medicinal materials, then extract as raw material according to the ratio of regulation.4 Chinese medicines and solid-liquid ratio extract according to the rules, guarantee that the basic effective constituents of extract is stablized.Adding the object of enzyme preparation is depolymerized pectin, cellulose and the macromolecular substances such as protein-based, reduce extract viscosity, for the unit operations such as subsequent film separation, reduced pressure concentration, spraying dry lay the first stone smoothly, yield and the solubility of extract can also be improved.The active carbon added, object is decolouring and drainage, guarantees that the extract color obtained is faint yellow.Crossing cleaner liquid sterilization is in order to the enzyme killing bacterium He add, and is convenient to subsequent unit operation steady quality.Preferred film aperture is the microfiltration membranes of 0.45 μm is in order to removal of impurities, clarification, is convenient to NF membrane operation, increases the service life, can also reduce retaining and losing of multiple polysaccharide component as far as possible.Selecting NF membrane to be to concentrate at normal temperatures, ensuring the quality of products, reducing costs.These technical characteristic fixed Combination together, can not put upside down, inseparable, supports mutually, acting in conjunction by order, just can obtain that dissolubility is good, cost is low, it is anti-oxidant, antibacterial to have, the Momordica grosvenori compound extract of develop immunitypty effect.Composite with persimmon powder further, make compound capsule; Persimmon powder extracts not to be placed in compound extract leaching process and goes, and is stablizing in order to ensure active constituent content in persimmon powder, guarantees quality stability and effect of compound capsule.Welded joint is novel, is not known technology, is not the superposition of simple technique combination, has outstanding substantive distinguishing features and significant progress.
Detailed description of the invention
The following stated example understands the present invention in detail.
Embodiment 1
The preparation of Part I Momordica grosvenori compound extract
1, Momordica grosvenori tentatively extracts
The pure water that new fresh fructus momordicae is first placed in 6 times of its quality is decocted, obtains Luohanguo's residue and Aqueous extracts A; Pure water Luohanguo's residue being placed in again 8 times of its quality decocts, and obtains Aqueous extracts B; A and B is merged, filters, obtain Momordica grosvenori just extract;
2, Momordica grosvenori glucoside separating substances
First for Momordica grosvenori extract is carried out reduced pressure concentration, obtains concentrate; Concentrate is carried out plate-frame filtering, obtains concentrate clear liquid; By Momordica grosvenori concentrate clear liquid D101 styrene type EVA macroporous resin adsorption, decolouring; Reclaim Momordica grosvenori efflux;
3, with Momordica grosvenori efflux for solvent extracts
Take qualified stem tea 200kg, dry aloe leaf 100kg, dry shrub althea flower 120kg, dry sweet basil 50kg as raw material; Extract in the extractor of 5 tons for solvent with 3000kg Momordica grosvenori efflux, be first heated to 70 DEG C, then open auxiliary ultrasonic and extract, after 4 hours, extract and terminate.
After extraction terminates, through vibratory sieve, extract is separated with the dregs of a decoction; Then extract is cooled to 50 DEG C.
4, enzymolysis, decolouring, filtration, sterilization
Take pectase 0.5kg, papain 2.0 kg, cellulase 1.0kg, add the water-soluble solution of 10kg, stir, then join in the extract of 2000kg, carry out enzymolysis, control temperature is 50 DEG C, and the time is 30 minutes; Add the Powdered Activated Carbon of 2.5kg again, continue insulation 30 minutes, decolour; Then filter with diatomite filter; During filtration, add the thick diatomite of 5kg, the thin diatomite of 5kg as filter aid, first carry out precoating, then filter, obtained cleaner liquid;
Crossing cleaner liquid adopts instantaneous superhigh temperature to kill bacterium (UHT) sterilization, and sterilization temperature controls at 125 DEG C, obtains extracting stoste 1800kg.
5, UF membrane
1800kg is extracted the micro-filtrate membrane filtration that stoste first uses 0.45 μm; Then at normal temperatures by NF membrane, concentrate, obtain nanofiltration concentrate 300kg, detecting soluble solid is 10.2%; Concentrate carries out reduced pressure concentration with single effect evaporator further, obtains high power concentrate 50kg, and detecting soluble solid is 51.2%.
6, dry
With spray drying device, high power concentrate 50kg is carried out spraying dry, obtain the Momordica grosvenori compound extract of 22.8kg.
The preparation of Part II Momordica grosvenori compound capsule
1, the Momordica grosvenori compound extract prepared by said method, the persimmon powder airslide disintegrating mill of purchase is pulverized respectively, crosses 200 mesh sieves, obtains qualified Momordica grosvenori compound extract and persimmon powder, for subsequent use; Cornstarch, maltodextrin, microcrystalline cellulose is pulverized with Universalpulverizer respectively, crosses 200 mesh sieves, for subsequent use.
2, take the cornstarch 30g crushed, Momordica grosvenori compound extract 25g, persimmon powder 10g, maltodextrin 30g, microcrystalline cellulose 5g, drop in mixer successively, fully mix, obtain mixture.
3, by mixture with 95% ethanol softwood, vibratory sieve granulate.
4, dressing.Take hydroxypropyl methylcellulose (HPMC) 20g, ethanol with 60% is made into the coating solution of 8%, and dressing controls dressing kettle temperature 35-40 DEG C, controls rotating speed at 30-35 turns/min, evenly spray into coating solution with high-pressure spray gun, and constantly stir particle.Until coating solution bag is complete.Take out, decompression (not heating) dry 2h, obtains qualified particle.
5, qualified particle 1# capsule shells is filled to the hard shell capsules of 0.3g every at capsule filling machine, polishing, then makes aluminium-plastic panel, and mounted box makes finished product.
Embodiment 2
Part I, the preparation of Momordica grosvenori compound extract
1, with Momordica grosvenori efflux for solvent extracts.
Take qualified stem tea 10kg, dry aloe leaf 2.5kg, dry shrub althea flower 5.0kg as raw material; With 100kg Momordica grosvenori efflux for solvent, extract in the extractor of 500L.First be heated to 90 DEG C, then open auxiliary ultrasonic and extract, after 6 hours, extract and terminate.After extraction terminates, through vibratory sieve, extract is separated with the dregs of a decoction; Then extract is cooled to 50 DEG C.
2, enzymolysis, decolouring, filtration, sterilization.
Take pectase 20g, papain 100g, cellulase 50g, join in the extract of 100kg, carry out enzymolysis, control temperature is 45 DEG C, and the time is 20 minutes; Add the Powdered Activated Carbon of 50g again, continue insulation 40 minutes, decolour; Then filter with diatomite filter, add diatomite as filter aid, obtained cleaner liquid;
Crossing cleaner liquid adopts instantaneous superhigh temperature to kill bacterium (UHT) sterilization, and sterilization temperature controls at 125 DEG C, obtains extracting stoste 80kg.
5, UF membrane.
80kg is extracted the micro-filtrate membrane filtration that stoste first uses 0.45 μm; Then concentrated by NF membrane at normal temperatures, obtain nanofiltration concentrate 8.6kg, detecting soluble solid is 13.5%.
6, dry
With freeze drying equipment, concentrate is carried out drying, obtain the Momordica grosvenori compound extract of 1.2kg.
Part II, the preparation of Momordica grosvenori compound capsule
1, the Momordica grosvenori compound extract prepared by said method, the persimmon powder airslide disintegrating mill of purchase is pulverized respectively, crosses 200 mesh sieves, obtains qualified Momordica grosvenori compound extract and persimmon powder, for subsequent use; Cornstarch, maltodextrin, microcrystalline cellulose is pulverized with Universalpulverizer respectively, crosses 200 mesh sieves, for subsequent use.
2, take the cornstarch 330g crushed, Momordica grosvenori compound extract 230g, persimmon powder 80g, maltodextrin 300g, microcrystalline cellulose 50g, drop in mixer successively, fully mix, obtain mixture.
3, by mixture with 95% ethanol softwood, vibratory sieve granulate.
4, dressing.Take hydroxypropyl methylcellulose (HPMC) 20g, the ethanol with 60% is made into the coating solution of 8%, carries out dressing.Take out, do not heat and carry out drying under reduced pressure 2h, obtain qualified particle.
5, qualified particle 1# capsule shells is filled to the hard shell capsules of 0.3g every at capsule filling machine, polishing, then makes aluminium-plastic panel, and mounted box makes finished product.
Embodiment 3
1, with Momordica grosvenori efflux for solvent extracts.
Take qualified stem tea 2kg, dry aloe leaf 2kg, dry shrub althea flower 1.5kg, dry sweet basil 1.0kg as raw material; With 60kg Momordica grosvenori efflux for solvent, extract in the extractor of 100L, be first heated to 70 DEG C, carry out extraction 4 hours.After extraction terminates, be separated through dreg-liquid separator, extract is separated with the dregs of a decoction; Then extract is cooled to 50 DEG C.
Be solvent with 60kg Momordica grosvenori efflux again, repeat extraction 2 times.Merge cooled extract.
2, enzymolysis, decolouring, filtration, sterilization.
Take pectase 15g, protease 120g, cellulase 80g, join in 50kg extract, carry out enzymolysis, control temperature is 50 DEG C, and the time is 30 minutes; Add the Powdered Activated Carbon of 50g again, continue insulation 30 minutes, decolour; Then filter with diatomite filter; With diatomite as filter aid, first obtained cleaner liquid;
3, sterilization.
Cross cleaner liquid and adopt pasteurize, sterilization temperature controls at 95 DEG C, keeps 30 minutes, then cools, and obtains extracting stoste.
4, UF membrane.
Extraction stoste is first used the micro-filtrate membrane filtration of 0.45 μm; Then at normal temperatures by multi-functional NF membrane, concentrate, obtain nanofiltration concentrate.
6, dry
Concentrate 10kg is carried out spraying dry, with the Momordica grosvenori compound extract obtaining 1.8kg.
Part II, the preparation of Momordica grosvenori compound capsule
1, the Momordica grosvenori compound extract prepared by said method, the persimmon powder airslide disintegrating mill of purchase is pulverized respectively, crosses 200 mesh sieves, obtains qualified Momordica grosvenori compound extract and persimmon powder, for subsequent use; Cornstarch, maltodextrin, microcrystalline cellulose is pulverized with Universalpulverizer respectively, crosses 200 mesh sieves, for subsequent use.
2, take the cornstarch 330g crushed, Momordica grosvenori compound extract 270g, persimmon powder 100g, maltodextrin 250g, microcrystalline cellulose 50g, drop in mixer successively, fully mix, obtain mixture.
3, by mixture with 95% ethanol softwood, vibratory sieve granulate.
4, dressing.Take hydroxypropyl methylcellulose (HPMC) 20g, the ethanol with 60% is made into the coating solution of 8%, carries out dressing.Take out, do not heat and carry out drying under reduced pressure 2h, obtain qualified particle.
5, qualified particle 1# capsule shells is filled to the hard shell capsules of 0.3g every at capsule filling machine, polishing, then makes aluminium-plastic panel, and mounted box makes finished product.
Claims (4)
1. a preparation method for Momordica grosvenori compound capsule, comprises and being pulverized by each supplementary material, sieve, mixing, granulates, and dressing is dry, capsule-filling, plate-making,
It is characterized in that: the proportioning of described Momordica grosvenori compound capsule is, by butt quality %,
Momordica grosvenori compound extract 23-27;
Persimmon powder 5-10;
Cornstarch 30-35;
Maltodextrin 25-30;
Microcrystalline cellulose 5-10;
Dressing adopts 2.0% hydroxypropyl methylcellulose (HPMC), and coating solution adopts the ethanol of 60% to make solvent, and being made into concentration is 6.0%-8.0% coating solution.
2., according to the preparation method described in claim 1, described Momordica grosvenori compound extract adopts following processing step:
1) carry at the beginning of Momordica grosvenori
Take dried fructus momordicae as raw material, adopt pure water to extract, concentrated, column chromatography, wash-out, extracts Momordica grosvenori glucoside material, then reclaims the Momordica grosvenori efflux by column chromatography;
It is characterized in that: also adopt following steps:
2) with Momordica grosvenori efflux for solvent extracts
By stem tea, dry aloe leaf, dry shrub althea flower, dry sweet basil in mass ratio example weigh up, as raw material;
Stem tea: dry aloe leaf: dry shrub althea flower: the ratio of dry sweet basil is 2:(0.5-2.0): (1-1.5): (0.1-1);
With Momordica grosvenori efflux for solvent extracts; Quality solid-liquid ratio is 1:(5-10); Then be heated to 70-100 DEG C, the time is 4-8 hour, extracts;
3) filter, cool
After extraction terminates, through vibratory sieve, extract is separated with the dregs of a decoction; Extract cools;
4) enzymolysis, decolouring, filtration, sterilization
Add the pectase of 0.01-0.1% by extract mass ratio, the papain of 0.05-0.2%, the cellulase of 0.05-0.2%, control temperature is 40-55 DEG C, and the time is carry out enzymolysis in 20-30 minute;
Add the active carbon of 0.1%-2.5% again, insulation 30-50 minute, decolours, then filters;
Cross cleaner liquid and carry out sterilization, obtain extracting stoste;
5) UF membrane
Extraction stoste is first used micro-filtrate membrane filtration, then concentrates with NF membrane normal temperature;
Concentrate can reduced pressure concentration further, obtains high power concentrate;
6) dry
With spraying dry or freeze drying or other drying means, by the nanofiltration concentrate that obtains or high power concentrate drying, or pulverize further, obtain Momordica grosvenori compound extract.
3. method according to claim 1 and 2, is characterized in that: step 2) described in extract, repeat to extract dregs of a decoction 2-3 time with Momordica grosvenori efflux.
4. according to the Momordica grosvenori compound capsule that preparation method according to claim 1 obtains.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510298167.5A CN104886594B (en) | 2015-06-03 | 2015-06-03 | Preparation method of siraitia grosvenorii compound capsules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510298167.5A CN104886594B (en) | 2015-06-03 | 2015-06-03 | Preparation method of siraitia grosvenorii compound capsules |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104886594A true CN104886594A (en) | 2015-09-09 |
CN104886594B CN104886594B (en) | 2017-01-18 |
Family
ID=54019903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510298167.5A Active CN104886594B (en) | 2015-06-03 | 2015-06-03 | Preparation method of siraitia grosvenorii compound capsules |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104886594B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101177444A (en) * | 2006-11-11 | 2008-05-14 | 大闽食品(漳州)有限公司 | Method for extracting momordica grosvenori flavone glycoside from momordica grosvenori |
JP2011207814A (en) * | 2010-03-30 | 2011-10-20 | Cci Corp | Neurite outgrowth agent |
CN103013752A (en) * | 2012-12-14 | 2013-04-03 | 桂林普兰德生物科技有限公司 | Brewing method of grosvenor momordica fruit-persimmon wine |
CN104068391A (en) * | 2014-06-05 | 2014-10-01 | 桂林三宝生物科技有限公司 | Aloe and momordica grosvenori compound capsule with high mogroside IV content |
CN104069151A (en) * | 2014-06-03 | 2014-10-01 | 桂林三宝药业有限公司 | Preparation method of extract with high mogroside IV content |
-
2015
- 2015-06-03 CN CN201510298167.5A patent/CN104886594B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101177444A (en) * | 2006-11-11 | 2008-05-14 | 大闽食品(漳州)有限公司 | Method for extracting momordica grosvenori flavone glycoside from momordica grosvenori |
JP2011207814A (en) * | 2010-03-30 | 2011-10-20 | Cci Corp | Neurite outgrowth agent |
CN103013752A (en) * | 2012-12-14 | 2013-04-03 | 桂林普兰德生物科技有限公司 | Brewing method of grosvenor momordica fruit-persimmon wine |
CN104069151A (en) * | 2014-06-03 | 2014-10-01 | 桂林三宝药业有限公司 | Preparation method of extract with high mogroside IV content |
CN104068391A (en) * | 2014-06-05 | 2014-10-01 | 桂林三宝生物科技有限公司 | Aloe and momordica grosvenori compound capsule with high mogroside IV content |
Non-Patent Citations (2)
Title |
---|
周治德等: "芦荟罗汉果复方胶囊处方及其体外抗氧化作用探讨", 《中国酿造》 * |
程新坤: "罗汉果柿子饼汤可疗秋咳", 《健康天地》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104886594B (en) | 2017-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110304994A (en) | A method of extracting high-purity cannabidiol from industrial hemp | |
CN105011160A (en) | Eucommia ulmoides leaf and wild chrysanthemum flower nutritional powder processing method | |
CN103145869B (en) | A kind of preparation method of the extract containing momordica grosvenori polysaccharide | |
CN105767397A (en) | Spleen-invigorating and stomach-harmonizing gingko tea | |
CN101402657A (en) | Process for producing chestnut shell polyphenol | |
CN101463027B (en) | Method for extracting and separating flavone and anthocyanidin from elder fruit | |
CN103005438A (en) | Kaempferiae extract and preparation method and application thereof | |
CN102675398B (en) | A kind of method extracting momordica grosvenori glycoside V and farnesol from Grosvenor Momordica | |
CN103168876A (en) | Medlar black tea | |
CN107898868A (en) | The method that separated in synchronization prepares matrimony vine red pigment, polysaccharides and matrimony vine flavones from matrimony vine | |
CN105707316A (en) | Preparation method of common zinnia and common snapdragon tea powder | |
CN105732741B (en) | The method that perilla leaf extracts anthocyanin and ursolic acid | |
CN104771930B (en) | The Subcritical Water Extraction agent of polyphenols and extracting process in a kind of lotus solid waste | |
CN102031116A (en) | New method for preparing rosemary natural antioxidant | |
CN102805320A (en) | Natural cedrela sinensis powder and preparation method thereof | |
CN106924304A (en) | The extracting method of Sweet tea active ingredient | |
CN107501425A (en) | Fragrant solomonseal rhizome polyoses are carried out using radix polygonati officinalis leftover bits and pieces and wash the preparation method of the clear sugar element of pancreas | |
CN107183710A (en) | The method of acidic electrolytic water extraction purification green peel of walnut polyphenol | |
CN103652155A (en) | Instant molecular health-care tea | |
CN103652158A (en) | Instant molecular herbal tea of lotus leaf-mulberry leaf-chrysanthemum tea | |
CN108813026A (en) | A kind of preparation process of folium cortex eucommiae wild chrysanthemum tea powder | |
CN104886594B (en) | Preparation method of siraitia grosvenorii compound capsules | |
CN104887577B (en) | A kind of preparation method of Momordica grosvenori compound gel | |
CN101366884B (en) | Preparation technique for compound formulation for reducing blood fat and blood sugar | |
CN104069140B (en) | A kind of method for preparing desmodium medicinal extract and its particle |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150909 Assignee: Guilin Xinjiatianxia Food Co.,Ltd. Assignor: GUILIN University OF ELECTRONIC TECHNOLOGY Contract record no.: X2023980046008 Denomination of invention: Preparation method of Luohanguo compound capsule Granted publication date: 20170118 License type: Common License Record date: 20231108 |